Our Committee Members 

Clinical Outcomes Improvement Committee

Purpose:
The Clinical Outcomes Improvement Committee assists hematopoietic progenitor cell transplant programs with improving patient outcomes by providing resources, creating tools, and reviewing corrective action plans.

Current members of Clinical Outcomes Improvement Committee:

Position

Name

Organization

City

Country

Chair

Amir Steinberg MD, FACP

Northwell Lenox Hill Hospital

Larchmont

United States

Member

Ibrahim Ahmed MD

Yas Clinic Khalifa City Hospital – in partnership with the Abu Dhabi Stem Cells Center: Clinical Program

Abu Dhabi

United Arab Emirates

Member
CIBMTR Ex Officio Rep

Jeff Auletta MD

NMDP/Be The Match

Minneapolis

United States

Member

Parastoo Bahrami Dahi MD

Memorial Sloan-Kettering Cancer Center - Blood and Marrow Transplant Program

New York

United States

Member
ASTCT Liaison

Christopher Dandoy MD, MS

Cincinnati Children's Hospital Medical Center, Cancer and Blood Diseases Institute, Bone Marrow Transplantation and Immune Deficiency Program

Cincinnati

United States

Member

Bhagirathbhai Dholaria MBBS

Vanderbilt University Medical Center/Veterans Affairs Tennessee Valley Healthcare System

Nashville

United States

Member

Rabi Hanna MD

Cleveland Clinic Blood and Marrow Transplant Program

Cleveland

United States

Member

Premal Lulla MD, MBBS

Houston Methodist Hospital and Texas Children’s Hospital

Houston

United States

Member

Stephen Medlin DO

Inova Stem Cell Transplant and Immunotherapy Program

Fairfax

United States

Member

Hemant Murthy MD

Blood and Marrow Transplantation Program of Mayo Clinic, Nemours Children's Clinic, and Wolfson Children's Hospital

Jacksonville

United States

Member

Eneida Nemecek MD

Northwest Marrow Transplant Program at Oregon Health & Science University, Legacy Good Samaritan Hospital and Medical Center and Doernbecher Children's Hospital

Portland

United States

Member

George Selby MD

Member

David Shyr MD

Stanford Medicine Blood & Marrow Transplantation and Cellular Therapy Program

Stanford

United States

Member

Michael Tees MD, MPH

Colorado Blood Cancer Institute at HCA HealthONE Presbyterian St. Luke’s, part of HCA Healthcare Sarah Cannon Cancer Network

Denver

United States

Member

Phyllis I. Warkentin MD

Foundation for the Accreditation of Cellular Therapy

Omaha

United States

Staff Liaison

Meghan Quinn

Foundation for the Accreditation of Cellular Therapy

Omaha

United States